Related Experiment Video
Updated: Oct 21, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Case Report: Hyperinflammatory Status in an Immunocompromised Child With a Highly Sustained Viral Load of SARS-CoV-2
Matias Moragas1, Sandra Gomez2, María Florencia Fernández1
1Unidad de Virología y Epidemiología Molecular - CONICET, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, Argentina.
Insights
This case study details a pediatric patient with acute myeloid leukemia who experienced a severe COVID-19 illness with a sustained high viral load and hyperinflammation. The findings highlight unique challenges in managing SARS-CoV-2 in immunocompromised children.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Immunology
Background:
- Limited data exist on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load dynamics in immunocompromised pediatric patients.
- Understanding these dynamics is crucial for managing Coronavirus disease 2019 (COVID-19) in vulnerable children.
Observation:
- A pediatric patient with acute myeloid leukemia presented with a unique hyperinflammatory status mimicking MIS-C during COVID-19 infection.
- The patient exhibited a sustained high SARS-CoV-2 viral load (approx. 7 log10 RNA copies/mL) for six weeks.
- Hyperinflammation developed early, coinciding with high viral load and immunocompromised status.
Findings:
- The clinical course involved late-onset fever, gastrointestinal symptoms, rash, and respiratory distress requiring oxygen.
- This case presents a unique combination of sustained high SARS-CoV-2 viral load, hyperinflammation, and an immunocompromised state in a pediatric oncology patient.
- The dynamics of SARS-CoV-2 viral load in immunosuppressed children remain largely unreported.
Implications:
- This case underscores the need for further research into COVID-19 in immunocompromised pediatric populations.
- Clinical management strategies may need to be adapted for pediatric patients with cancer and SARS-CoV-2 infection.
- Further studies are warranted to elucidate the interplay between immunosuppression, viral load, and hyperinflammation in pediatric COVID-19.
Abstract:
Coronavirus disease 2019 (COVID-19) is spreading throughout the world. Limited data are available for the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (VL) in immunocompromised pediatric patients. Here, we report the clinical characteristics and the dynamics of SARS-CoV-2 VL of a pediatric patient with acute myeloid leukemia who developed a hyperinflammatory status mimicked MIS-C. The clinical course was characterized by the late onset of fever, GI symptoms, rash, and respiratory distress, including oxygen requirement with sustained VL of SARS-CoV-2 around 7 log10 RNA copies/mL for 6 weeks. It is important to note that the hyperinflammatory status developed early at the third week of hospitalization-in a context of high VL and immunocompromised status. All these characteristics make this clinical case unique. On the other hand, while many reports have characterized the dynamics of SARS-CoV-2 VL in adults and immunocompetent hosts, it remains unreported in pediatrics-even less in immunosuppressed children.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013